bendroflumethiazide has been researched along with Obesity in 2 studies
Bendroflumethiazide: A thiazide diuretic with actions and uses similar to those of HYDROCHLOROTHIAZIDE. It has been used in the treatment of familial hyperkalemia, hypertension, edema, and urinary tract disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p810)
bendroflumethiazide : A sulfonamide consisting of 7-sulfamoyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide in which the hydrogen at position 6 is substituted by a trifluoromethyl group and that at position 3 is substituted by a benzyl group.
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ali, Q | 1 |
Hussain, T | 1 |
2 other studies available for bendroflumethiazide and Obesity
Article | Year |
---|---|
AT2 receptor non-peptide agonist C21 promotes natriuresis in obese Zucker rats.
Topics: Amiloride; Angiotensin II Type 1 Receptor Blockers; Animals; Bendroflumethiazide; Disease Models, An | 2012 |
Hypertension. I.
Topics: Adult; Bendroflumethiazide; Cerebrovascular Disorders; Coronary Disease; Diuretics; Female; Humans; | 1971 |